Evidence map›Paper›PMID 38446855›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Central tolerance shapes the neutralizing B cell repertoire against a persisting virus in its natural host.

Marianna Florova, Tiago Abreu-Mota, Guido C Paesen, Anna Sophia Beetschen, Karen Cornille, Anna-Friederike Marx, Kerstin Narr, Mehmet Sahin, Mirela Dimitrova, Nivedya Swarnalekha and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Chronic infection perturbs the affinity hierarchy of antiviral B cells.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Orf virus-based vectors induce potent germinal center B cell, Tfh cell, and CD8Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  6. Article
  7. Article
  8. Central tolerance shapes the neutralizing B cell repertoire against a persisting virus in its natural host.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Marianna Florova *Division of Experimental Virology, Department of Biomedicine, University of Basel, Basel 4009, Switzerland.
Tiago Abreu-Mota *Division of Experimental Virology, Department of Biomedicine, University of Basel, Basel 4009, Switzerland.
Guido C PaesenDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, United Kingdom.
Anna Sophia BeetschenDivision of Experimental Virology, Department of Biomedicine, University of Basel, Basel 4009, Switzerland.
Karen CornilleDivision of Experimental Virology, Department of Biomedicine, University of Basel, Basel 4009, Switzerland.
Anna-Friederike MarxDivision of Experimental Virology, Department of Biomedicine, University of Basel, Basel 4009, Switzerland.
Kerstin NarrDivision of Experimental Virology, Department of Biomedicine, University of Basel, Basel 4009, Switzerland.
Mehmet SahinDivision of Experimental Virology, Department of Biomedicine, University of Basel, Basel 4009, Switzerland.
Mirela DimitrovaDivision of Experimental Virology, Department of Biomedicine, University of Basel, Basel 4009, Switzerland.
Nivedya SwarnalekhaDepartment of Biomedicine, Immune Cell Biology Laboratory, University Hospital Basel, Basel 4031, Switzerland.ORCID 0000-0002-0998-8356
Jane Beil-WagnerInstitute of Laboratory Animal Science, University of Zurich, Zurich 8093, Switzerland.
Natasa SavicETH Phenomics Center, ETH Zürich, Zürich 8093, Switzerland.
Pawel PelczarCenter for Transgenic Models, University of Basel, Basel 4001, Switzerland.
Thorsten BuchInstitute of Laboratory Animal Science, University of Zurich, Zurich 8093, Switzerland.ORCID 0000-0002-2236-9074
Carolyn G KingDepartment of Biomedicine, Immune Cell Biology Laboratory, University Hospital Basel, Basel 4031, Switzerland.
Thomas A BowdenDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, United Kingdom.ORCID 0000-0002-8066-8785
Daniel D PinschewerDivision of Experimental Virology, Department of Biomedicine, University of Basel, Basel 4009, Switzerland.ORCID 0000-0002-1594-3189
University of Basel · CHCentre for Human Genetics · GBUniversity Hospital of Basel · CHUniversity of Zurich · CHETH Zurich · CH

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF) 310030_173132Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF) 310030_215043
6 · The paper itself

Abstract

Viral mimicry of host cell structures has been postulated to curtail the B cell receptor (BCR) repertoire against persisting viruses through tolerance mechanisms. This concept awaits, however, experimental testing in a setting of natural virus-host relationship. We engineered mouse models expressing a monoclonal BCR specific for the envelope glycoprotein of lymphocytic choriomeningitis virus (LCMV), a naturally persisting mouse pathogen. When the heavy chain of the LCMV-neutralizing antibody KL25 was paired with its unmutated ancestor light chain, most B cells underwent receptor editing, a behavior reminiscent of autoreactive clones. In contrast, monoclonal B cells expressing the same heavy chain in conjunction with the hypermutated KL25 light chain did not undergo receptor editing but exhibited low levels of surface IgM, suggesting that light chain hypermutation had lessened KL25 autoreactivity. Upon viral challenge, these IgM

Indexed as

B-LymphocytesCentral ToleranceAnimalsAntibodies, ViralAntiviral AgentsImmunoglobulin MLymphocytic choriomeningitis virusMiceAntibodies, ViralAntiviral AgentsImmunoglobulin MB cell receptor editingneutralizing antibodiespersistent viral infectionself-toleranceviral immune evasion

Identifiers

PMID38446855
PMCPMC10945855
OpenAlexW4392502768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.